NYK-1341

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNYK-1341
Drug Alias NameNYK-1341
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHSP70 heat-shock proteins stimulants
TargetsHSP70 heat-shock proteins
Therapy Area/IndicationsRejection of renal transplantationRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNykode Therapeutics ASA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNykode Therapeutics ASA
Active IndicationsN/A
Inactive IndicationsRejection of renal transplantationRenal Insufficiency

Other Information

ATC CodeN/A
Related LinksN/A